Drug utilization and recommended conditions for use in children;Utilización de medicamentos y condiciones de uso recomendadas en pediatría

Anales Espanoles de Pediatria

Volumn 57, Issue 5, 2002, Pages 414-419

  Danes Carreras I ^a   Vallano Ferraz, A ^a   De la Cruz Sugranes G ^a   Juarez Gimenez J C ^a   Arnau de Bolos J Ma ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Catalogs Drug; Drug approval; Drug utilization; Hospitalization; Pediatrics

Indexed keywords

ARTICLE; DATA ANALYSIS; DRUG APPROVAL; DRUG INFORMATION; DRUG UTILIZATION; HOSPITALIZATION; HUMAN; PEDIATRICS; PRESCRIPTION; RETROSPECTIVE STUDY; SPAIN;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DRUG UTILIZATION; HOSPITALIZATION; HUMANS; INFANT; RETROSPECTIVE STUDIES; SPAIN;

EID: 0036872080     PISSN: 03024342     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. 't Jong GW, Vulto AG, De Hoog M, Schimmel KJM, Tibboel D, Van den Anker JN. Unapproved and off-label use of drugs in a children's hospital. N Engl J Med 2000;343:1125.
2. 't Jong GW, Vulto AG, De Hoog M, Schimmel KJM, Tibboel D, Van den Anker JN. A survey of the use of off-label and unlicensed drugs in a Dutch children's hospital. Pediatrics 2001; 108:1089-93.
3. Conroy S, McIntyre J, Choonara I. Unlicensed and off label drug use in neonates. Arch Dis Child Fetal Neonatal Ed 1999; 80:F142-F5.
4. Turner S, Gill A, Nunn T, Hewit B, Choonara I. Use of "off-label" and unlicensed drugs in paediatric intensive care unit. Lancet 1996;347:549-50.
5. Impicciatore P, Choonara I. Status of new medicines approved by the European Medicines Evaluation Agency regarding paediatric use. Br J Clin Pharmacol 1999;48:15-8.
6. Gill AM, Leach HJ, Hughes J, Barker C, Nunn AJ, Choonara I. Adverse drug reactions in a paediatric intensive care unit. Acta Paediatr 1995;84:438-41.
7. Guidelines for ATC classification and DDD assignement. Oslo: WHO Collaborating Centre for Drug Stastistics Methodology, 1998.
8. Consejo General de Colegios Oficiales de Farmacéuticos. Catálogo de Especialidades Farmacéuticas. Madrid: Consejo General de Colegios Oficiales de Farmacéuticos, 1997.
9. Consejo General de Colegios Oficiales de Farmacéuticos. Catálogo de Especialidades Farmacéuticas. Madrid: Consejo General de Colegios Oficiales de Farmacéuticos, 2001.
10. th ed. Rockville: USP Pharmacopoeial Convention, 1997.
11. Riordan FAI. Use of unlabelled and off licence drugs in children. BMJ 2000;320:1210.
12. Turner S, Longworth A, Nunn AJ, Choonara I. Unlicensed and off label drug use in paediatric wards: Prospective study. BMJ 1998;316:343-5.
13. Turner S, Nunn AJ, Fielding K, Choonara I. Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: A prospective study. Acta Paediatr 1999;88:965-8.
14. Conroy S, Choonara I, Impicciatore P, Mohn A, Arnell H, Rane A, et al. Survey of unlicensed and off label drug use in paediatric wards in European countries. BMJ 2000;320:79-82.
15. McIntyre J, Conroy S, Avery A, Corns H, Choonara I. Unlicensed and off label prescribing of drugs in general practice. Arch Dis Child 2000;83:498-501.
16. Chalumeau M, Tréluyer JM, Salanave B, Assathiany R, Chéron G, Crocheton N, et al. Off label and unlicensed drug use among French office based paediatricians. Arch Dis Child 2000;83:502-5.
17. Wilson JT, Kearns GL, Murphy D, Yaffe SJ. Paediatric labelling requirements. Implications for pharmacokinetic studies. Clin Pharmacokinet 1994;26:308-25.
18. Choonara I, Conroy S. Unlicensed and off-label drug use in children. Implications for safety. Drug Saf 2002;25:1-5.
19. Royal College of Paediatrics and Child Healh, Neonatal and Paediatric Pharmacists Group. Medicines for Children. London: RCPCH Publications, 1999.